Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?

J Clin Oncol. 2006 Apr 1;24(10):1485-8. doi: 10.1200/JCO.2005.04.8801.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Endothelial Cells / drug effects*
  • Heart / drug effects*
  • Humans
  • Neoplasms / drug therapy*
  • Organophosphorus Compounds / adverse effects*

Substances

  • Antineoplastic Agents
  • N-acetylcochinol-O-phosphate
  • Organophosphorus Compounds